|
Market Closed -
Saudi Arabian S.E.
08:20:00 2026-09-06 EDT
|
5-day change | 1st Jan Change | ||
| 137.20 SAR | 0.00% |
|
-1.44% | -3.58% |
| 08-27 | Aljazira Capital Reduces Jamjoom Pharmaceuticals PT, Keeps at Neutral | MT |
| 08-27 | JamJoom Pharmaceuticals Kept at Neutral as AlJazira Capital Notes Q2 Results | MT |
Chart: Technical Analysis
Saudi Arabian S.E.SAR
| Markets | Quality | ||
|---|---|---|---|
Saudi Arabian S.E.
| 4015 | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Neutral |
| Resistance | 139.4 | 163.6 | 163.6 |
| Spread/Res. | -1.58% | -16.14% | -16.14% |
| Spread/Supp. | +1.93% | +7.19% | +5.21% |
| Support | 134.6 | 128 | 130.4 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- 4015 Stock
- Charts Jamjoom Pharmaceuticals Factory Company
Select your edition
All financial news and data tailored to specific country editions
